XNCR
XNCR
NASDAQ · Biotechnology

Xencor Inc

$12.64
-0.14 (-1.10%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 3 15%
Sell 0 0%
Price Target
Analyst Price Target +96.0% upside
Low Target $14.60
Average Target $24.77
High Target $27.54
Current Price $12.64
Current
$12.64
Target
$24.77
$14.60 $24.77 avg $27.54
Scenario Analysis
Bear Case
$14.60
15.5%
Low target
Base Case
$24.77
+96.0%
Avg target
Bull Case
$27.54
+117.9%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$18.69
-32.4% from high
52-Week Low
$6.92
+82.7% from low
Target vs 52W High
$24.77
+32.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%